Please login to the form below

Not currently logged in
Email:
Password:

Kala

This page shows the latest Kala news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Vedanta Biosciences appoints two new heads Vedanta Biosciences appoints two new heads

    Schopf formerly served as the senior director of preclinical development at Kala Pharmaceuticals and has over 20 years of industry experience.

  • ARC names chairman and member of the board ARC names chairman and member of the board

    Iwicki is executive chairman of the board of directors of Kala Pharmaceuticals and sits on the boards of Nimbus Therapeutics and Taris Biomedical.

  • Kala names Howard Rosen as chairman Kala names Howard Rosen as chairman

    Kala Pharmaceuticals has appointed life sciences industry veteran Howard Rosen as chairman of the board of directors. ... Kala's president and CEO Guillaume Pfefer commented on this rich experience when welcoming Rosen.

  • Allergan veteran joins Kala as head of business development Allergan veteran joins Kala as head of business development

    Charles McDermott has experience in ophthalmology. Charles McDermott, who has spent the last eight years at Allergan, has joined serious disease specialist Kala Pharmaceuticals as executive VP, business development. ... Kala will benefit from McDermott's

  • Kala Pharma appoints Fovea founder Bernard Gilly to board Kala Pharma appoints Fovea founder Bernard Gilly to board

    He previously formed the company that became Sanofi’s ophthalmology business. Dr Bernard Gilly, founder and CEO of Sanofi-owned Fovea, has joined the board of Kala Pharmaceuticals. ... He brings years of experience in eye treatment to Kala, which is

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....